TABLE 1.
Young adults | Older adults | ||
---|---|---|---|
(N = 10) | (N = 75) | p | |
Age | 32 (27–35.5) | 76 (71.5–83.5) | <0.001 |
Sex | 1.000 | ||
Female | 6 (60.0%) | 48 (64.0%) | |
Male | 4 (40.0%) | 27 (36.0%) | |
Site | 1.000 | ||
HSNRI | 5 (50.0%) | 37 (49.3%) | |
UCHC | 5 (50.0%) | 38 (50.7%) | |
Body-mass index | 28 (24.6–30.7) | 27 (24.4–31) | 0.692 |
Frailty index | — | 0.08 (0.032–0.128) | — |
CMV serostatus | 0.737 | ||
Negative | 5 (50.0%) | 31 (41.3%) | |
Positive | 5 (50.0%) | 44 (58.7%) | |
TNF (pg/ml) | 8 (6.45–9.14) | 11 (8.8–12.8) | <0.001 |
IL-6 (pg/ml) | 1 (0.819–1.85) | 3 (1.78–3.79) | 0.012 |
Continuous data presented as the median and interquartile range, and categorical data as count and frequency. Differences between age groups tested by Kruskal-Wallis or Fisher’s exact test, respectively. Note, the frailty index was not measured in younger adults.